Thryve, a San Francisco, CA-based provider of microbiotics and microbiome testing, closed a seed round of financing.
The amount of the deal was not disclosed.
Backers included PivotNorth Ventures and Plug & Play Ventures.
Led by Richard Lin, CEO, Thryve provides a monthly subscription service that combines customized home testing of the microbiome with a personalized probiotic created specifically for the individual. The company’s platform connects individuals with scientific research and online community to discover actionable insights into tackling microbiome related diseases. Its monthly Gut Wellness Score provides consumers with key insight into their health. The score analyzes the state of gut bacteria in the body, which clinical research has shown impacts not only overall all health, but also play a role the treatment and prevention of chronic diseases including obesity, cystic fibrosis, and Alzheimer’s. With each monthly box, subscribers also receive high quality probiotics aimed to improve gut health and overall wellness.